These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 11087571

  • 1. Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
    Boivin RP, Luu-The V, Lachance R, Labrie F, Poirier D.
    J Med Chem; 2000 Nov 16; 43(23):4465-78. PubMed ID: 11087571
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
    Ciobanu LC, Boivin RP, Luu-The V, Poirier D.
    J Enzyme Inhib Med Chem; 2003 Feb 16; 18(1):15-26. PubMed ID: 12751816
    [Abstract] [Full Text] [Related]

  • 4. 17Alpha-alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity.
    Boivin RP, Labrie F, Poirier D.
    Steroids; 1999 Dec 16; 64(12):825-33. PubMed ID: 10576217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors.
    Ciobanu LC, Luu-The V, Poirier D.
    J Steroid Biochem Mol Biol; 2002 Mar 16; 80(3):339-53. PubMed ID: 11948019
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group.
    Ciobanu LC, Boivin RP, Luu-The V, Poirier D.
    Eur J Med Chem; 2001 Mar 16; 36(7-8):659-71. PubMed ID: 11600235
    [Abstract] [Full Text] [Related]

  • 8. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
    Fournier D, Poirier D.
    Eur J Med Chem; 2011 Sep 16; 46(9):4227-37. PubMed ID: 21782294
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A, Williams GJ, Howarth NM, Potter BV, Reed MJ.
    Biochemistry; 1995 Sep 12; 34(36):11508-14. PubMed ID: 7547880
    [Abstract] [Full Text] [Related]

  • 12. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW, Howarth NM, Purohit A, Hejaz HA, Reed MJ, Potter BV.
    J Med Chem; 1998 Mar 26; 41(7):1068-83. PubMed ID: 9544207
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
    Winum JY, Vullo D, Casini A, Montero JL, Scozzafava A, Supuran CT.
    J Med Chem; 2003 May 22; 46(11):2197-204. PubMed ID: 12747791
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.
    Selcer KW, Kabler H, Sarap J, Xiao Z, Li PK.
    Steroids; 2002 Sep 22; 67(10):821-6. PubMed ID: 12231117
    [Abstract] [Full Text] [Related]

  • 18. First dual aromatase-steroid sulfatase inhibitors.
    Woo LW, Sutcliffe OB, Bubert C, Grasso A, Chander SK, Purohit A, Reed MJ, Potter BV.
    J Med Chem; 2003 Jul 17; 46(15):3193-6. PubMed ID: 12852749
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.